Interleukin-6

 

Interleukin-6, which, among its other effects, stimulates the production of red blood cells and helps control metastases, was first isolated and cloned by Prof. Michel Revel.

 

 

Interleukin-6 was developed into a drug by InterPharm Laboratories Ltd. in Kiryat Weizmann, which uses it in advanced clinical trials.